Safety and Behavior of S. Aureus Immune Globulin Intravenous(Human), [Altastaph] in Patients With S. Aureus Bacteremia and Continuing Fever
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00063089 |
Recruitment Status
:
Completed
First Posted
: June 20, 2003
Last Update Posted
: May 14, 2012
|
Sponsor:
Nabi Biopharmaceuticals
Information provided by (Responsible Party):
Nabi Biopharmaceuticals
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | September 2004 |
Actual Study Completion Date : | September 2004 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):